VistaGen Therapeutics, Inc. revenue breakdown overview

VistaGen Therapeutics, Inc. revenue for the last year amounted to -227.30 k USD, the most of which — -227.30 k USD — came from its highest performing source at the moment, Central Nervous System Therapies, the year earlier bringing 1.11 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought VistaGen Therapeutics, Inc. -227.30 k USD, and the year before that — 1.11 M USD.